WASHINGTON UNIVERSITY
Investigating the Feasibility of Gene Therapy for the Treatment of TBRS
Investigating the Feasibility of Gene Therapy for the Treatment of TBRS is a funding opportunity from WASHINGTON UNIVERSITY, up to 36673, closing February 28, 2028.
Feb 28, 2028
(577d left)Overview
PROJECT SUMMARY Neurodevelopmental disorders (NDDs) often result from mutations in genes essential for brain development and function. Recent advances in gene replacement therapy have shown promise for rescuing molecular and behavioral deficits in mouse models, even when gene restoration occurs postnatally. However,…